BioCryst stock rises after $264 million sale of European ORLADEYO business – RP Digital

Business

BioCryst stock rises after $264 million sale of European ORLADEYO business

June 27, 20251 min0

BioCryst stock rises after $264 million sale of European ORLADEYO business

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

Trump touts a mineral rights deal with Congo

rpdigitalJune 27, 20250

Vault Ventures reports £156,965 loss for 2024, shifts to blockchain focus

rpdigitalJune 27, 20250